Jubilant Pharmova Limited (BOM:530019)

India flag India · Delayed Price · Currency is INR
1,107.65
+3.50 (0.32%)
At close: Aug 7, 2025
0.32%
Market Cap175.40B
Revenue (ttm)74.04B
Net Income (ttm)4.60B
Shares Out158.35M
EPS (ttm)28.97
PE Ratio38.24
Forward PE28.87
Dividend5.00 (0.45%)
Ex-Dividend DateJul 25, 2025
Volume5,253
Average Volume17,387
Open1,100.00
Previous Close1,104.15
Day's Range1,081.00 - 1,122.00
52-Week Range823.70 - 1,309.00
Beta0.70
RSI39.31
Earnings DateJul 18, 2025

About Jubilant Pharmova

Jubilant Pharmova Limited operates as an integrated pharmaceutical company in India, the Americas, Europe, and internationally. It operates through six segments: Radiopharma; Allergy Immunotherapy; Contract Development and Manufacturing Organisation - Sterile Injectables; Generics; Contract Research Development and Manufacturing Organisation; and Proprietary Novel Drugs. The Radiopharma segment offers radiopharmaceuticals products, which are used in the diagnosis and treatment of various diseases, including pulmonary embolism, cancer, coronary ... [Read more]

Industry Pharmaceutical Preparations
Founded 1978
Employees 5,399
Stock Exchange Bombay Stock Exchange
Ticker Symbol 530019
Full Company Profile

Financial Performance

In 2024, Jubilant Pharmova's revenue was 72.35 billion, an increase of 7.93% compared to the previous year's 67.03 billion. Earnings were 8.39 billion, an increase of 988.72%.

Financial Statements

News

Jubilant Food Share Price Target 2022

Jubilant Foodworks Limited (JUBLFOOD), the master franchisee of the Domino’s Pizza and Dunkin’ Donuts brands in India, has been of immense interest to investors in 2022, as the company’s shares have a...

15 days ago - ABC Money

QSR sector faces rising competition; CLSA cautious on Jubilant and Westlife, positive on Devyani and RBA

Global brokerage CLSA has highlighted a challenging competitive landscape in India’s quick service restaurant (QSR) sector, particularly in high-frequency categories like pizzas and burgers. In its la...

7 weeks ago - Business Upturn

Jubilant to buy 40% in Coke bottler's parent for 10k cr

Jubilant Bhartia Group is set to acquire a 40% stake in Hindustan Coca-Cola Holdings (HCCH), the parent company of India's largest Coca-Cola bottler, for over Rs 10,000 crore. This investment reflects...

8 months ago - The Times of India

Bernstein maintains Outperform rating on Jubilant Foodworks, highlights three pillars to achieve $10 billion market cap

Bernstein maintains an Outperform (O-P) rating on Jubilant Foodworks, with a target price of ₹700, highlighting three critical growth pillars needed for Jubilant to achieve a market cap of ₹80,000 cro...

9 months ago - Business Upturn

Eagle Pharmaceuticals Appoints Christopher Krawtschuk as Chief Financial Officer

WOODCLIFF LAKE, N.J., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Eagle Pharmaceuticals, Inc. (OTC: EGRX) (the "Company" or "Eagle") today announced the appointment of Christopher Krawtschuk as Chief Financial...

9 months ago - Benzinga

CLSA maintains ‘Underperform’ rating on Jubilant FoodWorks with target price of Rs 445, expecting 26% downside

CLSA has reiterated its ‘Underperform’ rating on Jubilant FoodWorks, setting a target price of ₹445, indicating a potential 26% downside from the current market price (CMP) of ₹602.60. Key insights fr...

9 months ago - Business Upturn

Jefferies maintains ‘Buy’ rating on Jubilant FoodWorks with target price of Rs 880, expecting 46% upside

Jefferies has reiterated its ‘Buy’ rating on Jubilant FoodWorks, setting a target price of ₹880, indicating a potential 46% upside from the current market price (CMP) of ₹602.60. Key takeaways from Je...

9 months ago - Business Upturn

Morgan Stanley maintains ‘Equal-weight’ rating on Jubilant FoodWorks with target price of Rs 620

Morgan Stanley has reiterated its ‘Equal-weight’ rating on Jubilant FoodWorks, setting a target price of ₹620, indicating a modest upside from the current market price (CMP) of ₹602.60. Key insights f...

9 months ago - Business Upturn

Stocks to Watch: RIL, Adani Enterprises, BEL, GAIL, Kaynes Technology, Lupin, Jubilant Pharma, Zomato and morein focus today (Sept 30, 2024)

Indian benchmark indices ended lower on September 27, with the Nifty slipping below 26,200. The BSE Midcap and Smallcap indices remained relatively flat. The top losers on the Nifty included Power Gri...

11 months ago - Business Upturn